» Articles » PMID: 33652356

Alzheimer's Disease and Its Treatment by Different Approaches: A Review

Overview
Journal Eur J Med Chem
Specialty Chemistry
Date 2021 Mar 2
PMID 33652356
Citations 106
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer's disease (AD) is a neurodegenerative disorder that impairs mental ability development and interrupts neurocognitive function. This neuropathological condition is depicted by neurodegeneration, neural loss, and development of neurofibrillary tangles and Aβ plaques. There is also a greater risk of developing AD at a later age for people with cardiovascular diseases, hypertension and diabetes. In the biomedical sciences, effective treatment for Alzheimer's disease is a severe obstacle. There is no such treatment to cure Alzheimer's disease. The drug present in the market show only symptomatic relief. The cause of Alzheimer's disease is not fully understood and the blood-brain barrier restricts drug efficacy are two main factors that hamper research. Stem cell-based therapy has been seen as an effective, secure, and creative therapeutic solution to overcoming AD because of AD's multifactorial nature and inadequate care. Current developments in nanotechnology often offer possibilities for the delivery of active drug candidates to address certain limitations. The key nanoformulations being tested against AD include polymeric nanoparticles (NP), inorganic NPs and lipid-based NPs. Nano drug delivery systems are promising vehicles for targeting several therapeutic moieties by easing drug molecules' penetration across the CNS and improving their bioavailability. In this review, we focus on the causes of the AD and their treatment by different approaches.

Citing Articles

Altered spatiotemporal consistency and their genetic mechanisms in mild cognitive impairment: a combined neuroimaging and transcriptome study.

Zhu Y, Wang A, Zhou Y, Yuan S, Ji Y, Hu W Cereb Cortex. 2025; 35(2).

PMID: 40037416 PMC: 11879177. DOI: 10.1093/cercor/bhaf045.


Trends of the Dementia Burden in South Asia: An Analysis of 2021 Global Burden of Disease Study.

Chauhan S, Jena D, Gaidhane S, Dev N, Bushi G, Priya G Aging Med (Milton). 2025; 8(1):e70002.

PMID: 40017668 PMC: 11865018. DOI: 10.1002/agm2.70002.


Therapeutic Role of Heterocyclic Compounds in Neurodegenerative Diseases: Insights from Alzheimer's and Parkinson's Diseases.

Puranik N, Song M Neurol Int. 2025; 17(2).

PMID: 39997657 PMC: 11858632. DOI: 10.3390/neurolint17020026.


IGF1R/ARRB1 Mediated Regulation of ERK and cAMP Pathways in Response to Aβ Unfolds Novel Therapeutic Avenue in Alzheimer's Disease.

Sengupta P, Mukhopadhyay D Mol Neurobiol. 2025; .

PMID: 39969678 DOI: 10.1007/s12035-025-04735-6.


"Advances in biomarker discovery and diagnostics for alzheimer's disease".

Bhatia V, Chandel A, Minhas Y, Kushawaha S Neurol Sci. 2025; .

PMID: 39893357 DOI: 10.1007/s10072-025-08023-y.